Alkermes to Host Conference Call to Discuss First Quarter 2021 Financial Results
Alkermes plc (Nasdaq: ALKS) announced a conference call and webcast to discuss its first quarter 2021 financial results on April 28, 2021, at 8:00 a.m. ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Alkermes plc (Nasdaq: ALKS) announced a conference call and webcast to discuss its first quarter 2021 financial results on April 28, 2021, at 8:00 a.m. ET. The call will provide insights into the company's performance and updates on its operations. Interested parties can access the webcast and slides on Alkermes' website, and a replay will be available until May 5, 2021. Alkermes specializes in developing innovative medicines in neuroscience and oncology, with a focus on conditions such as addiction and schizophrenia.
Details
News Market Reaction – ALKS
The recorded move for ALKS in the trading session of this news was +2.05%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
DUBLIN, April 21, 2021 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET (1:00 p.m. BST) on Wednesday, Apr. 28, 2021 to discuss the company's first quarter 2021 financial results. Management will also provide an update on the company.
The webcast player and accompanying slides may be accessed on the Investors section of Alkermes' website at www.alkermes.com. The conference call may be accessed by dialing +1 877 407 2988 for U.S. callers and +1 201 389 0923 for international callers.
A replay of the conference call will be available from 11:00 a.m. ET (4:00 p.m. BST) on Wednesday, Apr. 28, 2021, through Wednesday, May 5, 2021, and may be accessed by visiting Alkermes' website or by dialing +1 877 660 6853 for U.S. callers and +1 201 612 7415 for international callers. The replay access code is 13718854.
About Alkermes plc
Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on addiction and schizophrenia, and a pipeline of product candidates in development for schizophrenia, bipolar I disorder, neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.
Alkermes Contact:
Alex Braun
Investor Relations
+1 781 296 8493
View original content to download multimedia:http://www.prnewswire.com/news-releases/alkermes-to-host-conference-call-to-discuss-first-quarter-2021-financial-results-301274155.html
SOURCE Alkermes plc
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.